首页> 外文期刊>Technical Innovations & Patient Support in Radiation Oncology >Dosimetric analysis of Deep Inspiratory Breath-hold technique (DIBH) in left-sided breast cancer radiotherapy and evaluation of pre-treatment predictors of cardiac doses for guiding patient selection for DIBH
【24h】

Dosimetric analysis of Deep Inspiratory Breath-hold technique (DIBH) in left-sided breast cancer radiotherapy and evaluation of pre-treatment predictors of cardiac doses for guiding patient selection for DIBH

机译:左侧乳腺癌放射治疗深吸气呼吸术(DibH)的剂量分析及心脏剂量前治疗预测因子的评价,用于DIBH的患者选择

获取原文
       

摘要

Introduction The risk of radiotherapy-associated cardiovascular disease has been a concern for decades in breast cancer survivors. The objective of our study is to evaluate the dosimetric benefit of Deep Inspiratory Breath-hold technique (DIBH) on organs-at-risk (OAR) sparing in left-sided breast cancer radiotherapy and to find out pre-treatment predictors of cardiac doses for guiding patient selection for DIBH. Material and methods Pre-radiotherapy planning CT scans were done in Free Breathing (FB) and in DIBH [using Active Breathing Coordinator system (ABC?)] in 31 left sided breast cancer patients. 3DCRT plans were generated for both scans. Comparison of anatomical and dosimetric variables were done using paired t test and correlation was evaluated using Pearson correlation. Linear regression was used to get independent predictors of cardiac sparing and Receiver Operating Characteristic (ROC) curve analysis was done to find out the specific threshold of the predictors. Results There was a 39.15% reduction in mean heart dose in DIBH compared to FB (2.4?Gy vs 4.01?Gy) (p??0.001), 19% reduction in maximum Left Anterior Descending (LAD) dose and a 9.9% reduction in ipsilateral lung mean dose (p?=?0.036) with DIBH. A significant correlation was observed between reduction in Heart Volume in Field (HVIF) and Maximum Heart Depth (MHD) with reduction in mean heart dose. Reduction in HVIF (ΔHVIF) independently predicted cardiac sparing. Conclusion DIBH leads to significant reduction in OAR doses and is suggested for all patients of left-sided breast cancer undergoing radiotherapy. However, HVIF and MHD predicted for cardiac sparing and threshold criteria of ΔHVIF and ΔMHD may be used by centres with high workload to select patients for DIBH.
机译:引言放射治疗相关心血管疾病的风险对于乳腺癌幸存者几十年来表示关注。我们研究的目的是评估深吸气呼吸持有技术(DIBH)对左侧乳腺癌放射治疗的余量(OAR)对左侧风险(OAR)进行的剂量效益,并找出心脏剂量的预处理预测因子为DIBH引导患者选择。材料和方法预放射治疗计划CT扫描在31例左侧乳腺癌患者中以自由呼吸(FB)和DIBH [使用主动呼吸协调器系统(ABC→)]进行。两种扫描都会生成3DCR的计划。使用配对T测试进行解剖学和剂量变量的比较,并使用Pearson相关评估相关性。线性回归用于获得心脏备用的独立预测器,并完成接收器操作特性(ROC)曲线分析以找出预测器的特定阈值。结果与FB(2.4〜4.01〜401〜4.01〜4.01〜4.01〜4.01〜4.01)相比,DIBH中的平均心脏剂量减少了39.15%(P 1 0.001),最大左前期下降(LAD)剂量减少19%和9.9%减少同侧肺部意味着Dibh的剂量(p?= 0.036)。在田间(HVIF)中的心脏体积和最大心脏深度(MHD)的降低之间观察到显着的相关性,随着平均心脏剂量的降低。减少HVIF(ΔHVIF)独立地预测心脏备量。结论DIBH导致OAR剂量的显着降低,并为所有左侧乳腺癌患者进行了放射治疗。然而,HVIF和MHD预测的ΔHVIF和ΔMHD的心脏备量和阈值标准可以由具有高工作量的中心使用,以为DIBH选择患者。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号